| retinol = vitamin A alcohol the primary dietary source, transport, and storage form retinal = vitamin A aldehyde retinoic acid = vitamin A acid = the biologically active form   | • | retinol in the human skin cells must be oxidated to retinoic acid | 
| • | metabolism of retinoids occurs mainly in the liver | 
| • | beta carotene is converted (in the intestine) to 2 molecules of retinal | 
  nuclear receptors for retinoids: | • | belong to a superfamily of receptors that act as DNA transcription factors and include steroid, vitamin D, and thyroid hormone receptors | 
| • | retinoid action = “physiologic instead of cytotoxic” i.e. induce differentiation to dysplastic epithelium | 
  retinoids treat disorders of cornification: | • | the ichthyoses (hyperproliferative vs. retention hyperkeratosis) | 
| • | psoriasis  (hyperproliferative epidermis) | 
| • | acne  (excessive desquamation of follicular epithelium in sebaceous follicles) | 
      SIDE EFFECTS:   acute toxicity: | • | pseudotumor cerebri (rare) | 
| • | persistent headaches with visual changes, nausea, and vomiting | 
| • | d/c and examine for papilledema | 
  lab abnormalities: | • | increase triglycerides – dose dependent and reversible | 
| • | d/c if levels reach 800mg/dL or higher | 
| • | occur in 15% of patients, but usually return to normal within 2 to 4 weeks | 
| • | acute hepatotoxic reactions may occur with fever and eosinophilia, possibly indicating hypersensitivity | 
  chronic toxicity (after long term use; > 2 years) | • | may result in demineralization of bones, premature closure of epiphysis resulting in shorter stature, and calcification of tendons and ligaments | 
    SPECIFIC RETINOIDS:   Panretin (alitretinoin) - topical treatment for Kaposi's Sarcoma Targretin (baxarotene) - oral treatment for Mycoses Fungoides   
| Guy Webster: | • | for patient with truncal acne, will start Accutane with PO prednisone (20-40mg/day X first month) to avoid flare with keloids | 
  
| | • | rarely re-treats after less than 4 months | 
| • | unknown how many times one can retreat (he has treated as often as 6 times) | 
| • | 2-4 weeks repeat triglycerides, monitor until they plateau | 
| • | 4-6 weeks repeat liver profile (again at end of treatment, or after 4 months) | 
| • | contact lenses (extra lubricant, try not to wear overnight) | 
 |     adverse effects: | • | acute – increased triglycerides, LFT’s, dryness, hair loss, pseudotumor cerebri | 
| • | chronic (>2 years) – demineralization of bones, premature closure of the epiphyses (short stature), calcification of tendons and ligaments | 
  total dose goal = 120 to 150 mg/kg (typically takes 6 months to achieve this total dose) |   acitretin: | • | = the free acid metabolite of etretinate | 
| • | decreased potential for post treatment teratogenicity | 
 |